Table 4.
Anti-mycobacterial activity of Nfz and 4-hydroxybenzhydrazone derivatives.
| Compound | MABA MIC (µg/mL) |
|---|---|
| Nfz | 12.3 |
| Nfz-1 | 5.1 |
| Nfz-2 | 18.8 |
| Nfz-3 | >100 |
| Nfz-4 | >100 |
| Nfz-5 | >100 |
| Nfz-6 | >100 |
| Nfz-7 | 98.3 |
| Nfz-8 | 79.4 |
| Nfz-9 | 94.1 |
| Nfz-10 | 47.6 |
| Nfz-11 | >100 |
| Nfz-12 | >100 |
| Nfz-13 | 157.8 |
| Nfz-14 | >200 |
| Nfz-15 | >100 |
| Nfz-16 | 46.4 |
| Nfz-17 | 43.6 |
| Nfz-18 | 186.4 |
| Nfz-19 | >100 |
| Nfz-20 | >100 |
| Nfz-21 | 68.7 |
| Nfz-22 | >100 |
| Nfz-23 | >100 |
| Nfz-24 | >100 |
| Nfz-25 | 45.9 |
| Isoniazid | 0.039 |
| Rifampin | 0.074 |
| Moxifloxacin | 0.184 |
| Linezolid | 0.330 |